Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lots of premature talk about loss of the MMP or PDS interest by TPL.

Are you suggesting that a judge could persuade PTSC to agree to a sale of TPL, contrary to the terms of contract, or something else? Please explain.

.

.

.

Be well

Share
New Message
Please login to post a reply